Government approves sale of IMPCL to Skymap Pharmaceuticals

Source:The Economic Times

02 — Who / Subject

Government of India, Skymap Pharmaceuticals

03 — Where / Locus

India

04 — When / Temporality

May 26, 2026

Verified: May 26, 2026

05 — Why / Core Summary

"The Indian government approved the sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL). Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore."

Conflict Analysis

A strategic divestment of a state-owned enterprise involved in Ayurvedic and Unani medicine manufacturing.

Post

COMPAMIR

COMPAMIR

Government approves sale of IMPCL to Skymap Pharmaceuticals